BBH ETF holdings (NASDAQ) | MetaTrader

Apri il grafico completo Full chart

Panoramica Tutti gli asset Mappa di calore

Principali partecipazioni Market Value Shares Weight %

AMGN Amgen Inc 56.71 M 173.27 K 15.09%

GILD Gilead Sciences Inc 54.04 M 440.31 K 14.38%

VRTX Vertex Pharmaceuticals Inc 34.29 M 75.64 K 9.12%

REGN Regeneron Pharmaceuticals Inc 29.05 M 37.63 K 7.73%

ARGX Argenx SE 17.74 M 21.10 K 4.72%

IQV IQVIA Holdings Inc 17.09 M 75.83 K 4.55%

ALNY Alnylam Pharmaceuticals Inc 16.62 M 41.79 K 4.42%

NTRA Natera Inc 16.08 M 70.21 K 4.28%

INSM Insmed Inc 15.50 M 89.03 K 4.12%

ONC BeOne Medicines Ltd 11.91 M 39.21 K 3.17%

BIIB Biogen Inc 11.87 M 67.44 K 3.16%

UTHR United Therapeutics Corp 11.17 M 22.93 K 2.97%

ILMN Illumina Inc 9.80 M 74.70 K 2.61%

ICLR ICON PLC 9.24 M 50.70 K 2.46%

Exact Sciences Corp 8.28 M 81.57 K 2.20%

INCY Incyte Corp 7.36 M 74.49 K 1.96%

NBIX Neurocrine Biosciences Inc 7.33 M 51.65 K 1.95%

BNTX BioNTech SE 6.85 M 71.93 K 1.82%

MRNA Moderna Inc 5.97 M 202.39 K 1.59%

CRL Charles River Laboratories International Inc 5.23 M 26.21 K 1.39%

1
2

Notizie

First Quarter Earnings: Sharpening Sector Divergence

3 Reasons To Stick With Growth Stocks In Rotating Markets

Seeking Innovation Beyond Tech? Insight On Healthcare Stocks

What Are Wall Street Analysts' Target Price for Vertex Pharmaceuticals Stock?

Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts

Should You Invest in the VanEck Biotech ETF (BBH)?

What's The Dominant Trend In Earnings: AI Or Geopolitics?

Medical Technology Stocks: Innovation Endures As Valuations Reset

AI And The Future Of Healthcare

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Can Forgotten Biotech Break Out?

Concerns Shift From Obsolescence To Oil